AHK-Cu 50mg

What it is

AHK-Cu is a complex of copper and the three-amino-acid sequence alanine–histidine–lysine. It is distinct from GHK-Cu, another copper peptide that appears frequently in skin-related literature.

The Welcuren presentation is labelled AHK-Cu 50mg and supplied as a branded pre-filled pen with case. This presentation does not itself demonstrate clinical effectiveness, safety or regulatory approval.

Why people ask about it

People often ask about AHK-Cu after reading about copper peptides, hair follicle biology or skin ageing. Much of the interest comes from early scientific findings and online discussion, rather than established outcomes in people.

Our clinicians help distinguish laboratory observations from clinical evidence, so that decisions reflect both the uncertainty and your individual circumstances.

What the science says

AHK-Cu has been investigated in isolated human hair follicles and cultured cells, including dermal papilla cells and skin-related cell models. Although these studies explore biological activity, work on human tissue outside the body is not equivalent to a clinical study in people.

There is insufficient high-quality clinical evidence to establish meaningful hair or skin benefits, optimal use or long-term safety for this presentation. Evidence from topical products, animal studies or other copper peptides cannot validate the branded pre-filled pen.

Is it right for me?

Access requires an online consultation, a review of your medical history and medicines, and approval by our clinicians. A consultation does not guarantee a prescription. AHK-Cu is not an established licensed option for hair or skin concerns in the UK; any proposed supply should be clearly explained as unlicensed before you decide whether to proceed.

It is not suitable for under-18s or during pregnancy or breastfeeding because adequate safety evidence is lacking. A history of cancer, active cancer, disorders of copper metabolism, significant liver or kidney disease, or known allergy to an ingredient requires particular consideration and may rule out prescribing. Please disclose all medicines, supplements and relevant diagnoses.

How Welcuren works

Complete a short online consultation about your health and goals.

A clinician reviews your answers, may ask follow-up questions, and decides whether this treatment is appropriate for you.

You only pay once treatment is approved. Our licensed facility then dispatches it with full instructions, on tracked global delivery.

Safety

The side-effect profile of this AHK-Cu presentation is not well characterised. Possible concerns include local irritation, redness, discomfort and allergic reactions; their frequency and severity are uncertain. Long-term risks and interactions with medicines or supplements have not been adequately established.

Our clinicians will discuss uncertainties, assess whether appropriate monitoring is possible and review any reported symptoms. Supply through our licensed facility does not mean that AHK-Cu itself holds a medicines licence or that safety and effectiveness have been established. Seek urgent medical help for signs of a severe allergic reaction, such as breathing difficulty or swelling of the face or throat.